The company is using artificial intelligence, and planning to help others use AI empowered by its data collection. Ginkgo Bioworks (DNA -5.64%) is a biotech that's going big on artificial intelligence (AI). Between its need to perform core workflows with high efficiency, and its generation of tons of biological and manufacturing data that demand analysis, Ginkgo will likely find AI becoming more important to it over time. That's especially true if it starts selling a key input that other biopharma companies ...